NCT06814951 Acute Effect of the Thoraco-abdominal Rebalance Method Postoperative Cardiac Surgery
| NCT ID | NCT06814951 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Instituto de Cardiologia do Rio Grande do Sul |
| Condition | Respiratory Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2024-09-01 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Introduction: The thoracoabdominal rebalancing (TAR) method aims to promote diaphragmatic juxtaposition, in addition to seeking to increase respiratory muscle strength and adjust muscle tone. However, scientific publications on this method in heart patients undergoing coronary artery bypass grafting (CABG) are still scarce, justifying the need to carry out this study for information, evaluation, diagnosis and treatment purposes in the health area with an emphasis on cardiology. Objective: To evaluate whether diaphragmatic ultrasound findings differ between the TAR method and conventional physiotherapy in post-CABG patients. Methods: This is a randomized, single-blind clinical trial. Adults (\>35 years), hemodynamically stable, who underwent CABG (\<24 hours) and had a prescription for physiotherapy will be included. Patients will be randomized into two groups: 1) intervention group \[IG\] - TAR; 2) control group \[CG\] - standard physiotherapy approach. Interventions will be performed at a single time and the following variables will be collected pre- and post-intervention: heart rate (HR), respiratory rate (RR), peripheral oxygen saturation (SpO2), mean arterial pressure (MAP), diaphragmatic ultrasound (US) to identify possible acute findings in both groups, respiratory distress scale and pulmonary complications scale will be applied at the end of the interventions. Keywords: Physiotherapy; Cardiology; Ultrasonography
Eligibility Criteria
Inclusion Criteria: * Individuals over 35 years of age who undergo coronary artery bypass graft surgery with prescribed physiotherapy treatment will be included in the study. Exclusion Criteria: * Patients who are intubated and/or have remained on mechanical ventilation for more than twelve hours, or who require non-invasive mechanical ventilation (NIV) before or during the collection period will be excluded.
Contact & Investigator
Instituto de Cardiologia do Rio Grande do Sul
PRINCIPAL INVESTIGATOR
Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brasil
Frequently Asked Questions
Who can join the NCT06814951 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, studying Respiratory Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06814951 currently recruiting?
Yes, NCT06814951 is actively recruiting participants. Contact the research team at karolinireis@hotmail.com for enrollment information.
Where is the NCT06814951 trial being conducted?
This trial is being conducted at Porto Alegre, Brazil.
Who is sponsoring the NCT06814951 clinical trial?
NCT06814951 is sponsored by Instituto de Cardiologia do Rio Grande do Sul. The principal investigator is Instituto de Cardiologia do Rio Grande do Sul at Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brasil. The trial plans to enroll 26 participants.